Avalo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	15.86	134.55	7.42	13.17	54.59
Short-Term Investments	82.48	-	-	-	-
Cash & Short-Term Investments	98.34	134.55	7.42	13.17	54.59
Cash Growth	-26.91%	1714.51%	-43.71%	-75.87%	188.52%
Accounts Receivable	-	-	-	-	1.06
Other Receivables	-	-	0.14	1.92	3.74
Total Trade Receivables	-	-	0.14	1.92	4.8
Inventory	-	-	-	0.02	0.04
Other Current Assets	6.95	4.34	0.84	1.31	2.42
Total Current Assets	105.29	138.89	8.4	16.42	61.85
Net Property, Plant & Equipment	0.46	1.21	1.97	2.41	2.7
Other Intangible Assets	-	-	-	-	0.04
Goodwill	10.5	10.5	10.5	14.41	14.41
Other Long-Term Assets	0.21	0.13	0.13	0.13	1.23
Total Assets	116.46	150.73	20.99	33.37	80.21
Accounts Payable	0.14	0.28	0.45	2.88	3.37
Accrued Expenses	12.8	6.32	4.17	13.21	16.52
Short-Term Debt	-	-	-	5.93	-
Unearned Revenue	-	-	-	0.09	-
Other Current Liabilities	-	0.36	-	-	-
Total Current Liabilities	12.94	6.96	4.62	22.11	19.89
Long-Term Debt	-	-	-	13.49	32.83
Other Long-Term Liabilities	20.47	10.74	9.07	8.68	4.41
Total Long-Term Liabilities	20.47	10.74	9.07	22.17	37.24
Total Liabilities	33.41	17.7	13.69	44.28	57.13
Common Stock	0.02	0.01	0	0	0.01
Additional Paid-in Capital	531.49	503.29	342.44	292.91	285.24
Accumulated Other Comprehensive Income	0.07	-	-	-	-
Retained Earnings	-448.52	-370.26	-335.13	-303.82	-262.17
Shareholders' Equity	83.05	133.03	7.3	-10.92	23.08
Total Liabilities & Equity	116.46	150.73	20.99	33.37	80.21
Total Debt	0	0	0	19.42	32.83
Net Cash (Debt)	98.34	134.55	7.42	-6.24	21.75
Net Cash Growth	-26.91%	1714.51%	-	-	14.97%
Net Cash Per Share	7.34	17.95	26.70	-22.48	-
Book Value	83.05	133.03	7.3	-10.92	23.08
Book Value Per Share	6.20	17.75	26.30	-39.30	-
Tangible Book Value	72.55	122.53	-3.2	-25.32	8.64
Tangible Book Value Per Share	5.41	16.35	-11.51	-91.18	-

Updated Mar 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q